Pfizer CEO switch may mean new strategy, shares up (Reuters)

Jeffrey B. Kindler, former Chairman and Chief Executive Officer of Pfizer, speaks during a news conference with former U.S. President Bill Clinton (not pictured), in New York, in this August 6, 2009 file photo. REUTERS/Chip EastReuters - Investors welcomed the sudden departure of Pfizer Inc CEO Jeffrey Kindler by pushing up the stock in the hopes that a new leader will more act more aggressively to revive the giant pharmaceutical company.